Risk Factors for Estrogen Receptor Subtype‐Specific Contralateral Breast Cancer in Women Under Age 55 Years
International Journal of Cancer · 01.01.2027 · 160 (1) · 57-71
DOI: 10.1002/ijc.70683 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 07.08.2026. Verfasst von Anne S Reiner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Neoplasms, Second Primary. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Women with estrogen receptor negative (ER‐) contralateral breast cancer (CBC) are 50% more likely to die of CBC compared to women with estrogen receptor positive (ER+) CBC. We comprehensively investigated risk factors for ER subtype‐specific CBC using the Women's Environmental Cancer and Radiation Epidemiology Study, a population‐based, case–control study of 1521 CBC cases under age 55 years and 2212 individually matched unilateral breast cancer controls. Information about breast cancer risk factors and ER status was obtained by interview and medical record abstraction and common genetic variants with GWAS. Multivariable rate ratios and 95% confidence intervals were estimated using conditional logistic regression models, adjusting for known and suspected risk factors. Among 2800 women where the matched case had known ER CBC status, chemotherapy, hormone therapy, and increasing number of full‐term pregnancies were associated with decreased ER+ CBC risk. Drinking, smoking, first breast cancer lobular histology, first‐degree breast cancer family history, a polygenic risk score (PRS) of 313 common variants, and an ER+ subtype‐specific PRS were associated with increased ER+ CBC risk. More than 2 years of breastfeeding was associated with decreased ER− CBC risk. While none of the PRSs were associated with ER− CBC risk, first‐ and second‐degree family history of breast cancer and second‐degree family history of ovarian cancer were associated with increased ER− CBC risk. We identified differential risk factors for ER subtype‐specific CBC which can inform individualized risk prediction models for future clinical impact. There remains an unexplained genetic component of ER− CBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- University of Iowa, Iowa City, Iowa, USA.
- Danish Cancer Institute, Copenhagen, Denmark.
- University of Toronto, Dalla Lana School of Public Health, Toronto, Canada.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada.
ORCID-Profile: Anne S Reiner, Lene Mellemkjær, Julia A Knight, Esther M John
Förderung
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Reiner, A. S., Malone, K. E., Lynch, C. F., Mellemkjær, L., Knight, J. A., John, E. M., Liang, X., Woods, M., WECARE Study Collaborative Group, & Bernstein, J. L. (2027). Risk Factors for Estrogen Receptor Subtype‐Specific Contralateral Breast Cancer in Women Under Age 55 Years. International Journal of Cancer, 160(1), 57-71. https://doi.org/10.1002/ijc.70683
Vancouver
Reiner AS, Malone KE, Lynch CF, Mellemkjær L, Knight JA, John EM, et al. Risk Factors for Estrogen Receptor Subtype‐Specific Contralateral Breast Cancer in Women Under Age 55 Years. International Journal of Cancer. 2027;160(1):57-71. doi:10.1002/ijc.70683
BibTeX
@article{Reiner2027,
author = {Reiner, Anne S and Malone, Kathleen E and Lynch, Charles F and Mellemkjær, Lene and Knight, Julia A and John, Esther M and Liang, Xiaolin and Woods, Meghan and WECARE Study Collaborative Group, WECARE Study Collaborative Group and Bernstein, Jonine L},
title = {Risk Factors for Estrogen Receptor Subtype‐Specific Contralateral Breast Cancer in Women Under Age 55 Years},
journal = {International Journal of Cancer},
year = {2027},
volume = {160},
number = {1},
pages = {57--71},
doi = {10.1002/ijc.70683}
}
EUVIMED